Live news related to VALNEVA stock (FR0004056851): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Valneva shares fell more than 3% this Thursday morning, dropping to 2.609 euros. The decline is part of a marked downward trend, with a nearly 37.5% d…
Valneva's stock increased by 5.83% this Wednesday morning to €2.73, in a Parisian market buoyed by a sharp rebound in the CAC 40 (+4.28% during the se…
Shares of the Nantes-based vaccine specialist experienced a sharp decline on Tuesday, April 7, trading at 2.566 euros at the end of the session. This …
Shares of the Nantes-based vaccine specialist fell by 3.4% this Thursday to €2.726, in a Parisian market significantly trending downward. This drop ex…
Shares of the Nantes-based vaccine specialist Valneva gained 4.47% this Wednesday, reaching 2.946 euros in a well-oriented Parisian market. This surge…
Valneva's stock is trading at 2.83 euros this Monday late morning, up 2.39% from Friday's close. This technical rebound follows a dramatic collapse of…
Valneva has announced its participation in several events at the 26th World Vaccine Congress, which will be held from March 31 to April 2, 2026, in Wa…
Stifel ajuste sa position sur Valneva ce mardi 24 mars 2026.
Pfizer and Valneva announced on Monday the positive results of the phase 3 VALOR clinical trial of their Lyme disease vaccine candidate. The companies…
The French vaccine laboratory recorded an operational loss of €82.1 million in 2025, despite a 3% increase in revenue to €174.7 million. This contradi…
